Abstract |
T-cadherin is gaining recognition as a determinant for the development of incipient invasive squamous cell carcinoma (SCC). However, effects of T-cadherin expression on the metastatic potential of SCC have not been studied. Here, using a murine model of experimental metastasis following tail vein injection of A431 SCC cells we report that loss of T-cadherin increased both the incidence and rate of appearance of lung metastases. T-cadherin-silenced SCC metastases were highly disordered with evidence of single cell dissemination away from main foci whereas SCC metastases overexpressing T-cadherin developed as compact, tightly organised sheets. SCC cell adhesion to vascular endothelial cells (EC) in culture was increased for T-cadherin-silenced SCC and decreased for T-cadherin-overexpressing SCC. Confocal microscopy showed that T-cadherin-silenced SCC adherent on EC display an elongated morphology with long thin extensions and a high degree of intercalation within the EC monolayer, whereas SCC overexpressing T-cadherin formed poorly-spread multicellular aggregates that remain on the outer surface of the EC monolayer. T-cadherin-deficient SCC or human keratinocyte cells exhibited increased transendothelial migration in vitro which could be attenuated in the presence of EGFR inhibitor gefitinib. Our data suggest that loss of T-cadherin can increase metastatic potential and aggressiveness of SCC, possibly due to facilitating arrest and extravasation through the vascular wall and/or more efficient establishment of metastases in the new microenvironment.
|
Authors | Maria Philippova, Dennis Pfaff, Emmanouil Kyriakakis, Stanislaw A Buechner, Giandomenica Iezzi, Giulio C Spagnoli, Andreas W Schoenenberger, Paul Erne, Therese J Resink |
Journal | European journal of cancer (Oxford, England : 1990)
(Eur J Cancer)
Vol. 49
Issue 8
Pg. 2048-58
(May 2013)
ISSN: 1879-0852 [Electronic] England |
PMID | 23369463
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Cadherins
- H-cadherin
- Protein Kinase Inhibitors
- Quinazolines
- ErbB Receptors
- Gefitinib
|
Topics |
- Animals
- Cadherins
(genetics, metabolism)
- Carcinoma, Squamous Cell
(genetics, metabolism, pathology)
- Cell Adhesion
(genetics)
- Cell Line, Tumor
- Cells, Cultured
- Coculture Techniques
- Endothelial Cells
(cytology, metabolism)
- ErbB Receptors
(antagonists & inhibitors, metabolism)
- Gefitinib
- Human Umbilical Vein Endothelial Cells
(cytology, metabolism)
- Humans
- Immunoblotting
- Keratinocytes
(cytology, metabolism)
- Lung Neoplasms
(genetics, metabolism, secondary)
- Mice
- Mice, Inbred NOD
- Mice, SCID
- Microscopy, Confocal
- Neoplasms, Experimental
(genetics, metabolism, pathology)
- Protein Kinase Inhibitors
(pharmacology)
- Quinazolines
(pharmacology)
- RNA Interference
- Skin Neoplasms
(genetics, metabolism, pathology)
- Transendothelial and Transepithelial Migration
(drug effects, genetics)
- Transplantation, Heterologous
|